HC Wainwright Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY)
HC Wainwright reissued their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a report published on Wednesday,Benzinga reports. The firm currently has a $75.00 price target on the stock. A number of other equities analysts have also commented on the company. Needham & Company LLC cut their price target on Harmony […]
HC Wainwright reissued their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a report published on Wednesday,Benzinga reports. The firm currently has a $75.00 price target on the stock. A number of other equities analysts have also commented on the company. Needham & Company LLC cut their price target on Harmony […]
